文献速递慢阻肺

高流量氧疗预防COPD患者支气管镜操作中血氧饱和度下降:随机对照PROSA 2试验

Preventing oxygen desaturation during bronchoscopy in COPD patients using high-flow oxygen versus standard management: the randomised controlled PROSA 2 trial.
PubMed 文献 · Eur Respir J · 2025-05-06

本研究为单中心、开放标签随机对照试验,纳入600例COPD患者,比较经鼻高流量氧疗与常规低流量鼻导管氧疗在支气管镜镇静操作中的效果,主要终点为累积低氧血症时间。结果显示高流量组累积低氧血症时间较低流量组降低53%,低氧血症事件更少,且低流量组发生低氧血症的比值比为5.1,高流量氧疗不改善患者舒适度。

要点

  • COPD患者支气管镜操作中,高流量氧疗显著降低累积低氧血症时间。
  • 高流量氧疗减少SpO2<90%的低氧血症事件次数。
  • 高流量氧疗不改善患者舒适度。

核心结论

  • 高流量氧疗在COPD患者支气管镜操作中可行,能降低累积低氧血症时间和低氧血症事件,但不影响患者舒适度。

研究设计与样本

  • 研究者发起的单中心、开放标签随机对照试验,纳入600例COPD患者,随机分为高流量组(n=295)和低流量组(n=305)。

主要发现

  • 高流量组累积低氧血症时间占监测时间的1.8%(95%CI 1.5-2.2%),低流量组为3.8%(95%CI 3.2-4.5%),p<0.001。
  • 高流量组中位低氧血症事件(SpO2<90%)为3.0(IQR 1.0-6.0)次,低流量组为6.0(IQR 3.0-10.0)次,p<0.001。
  • 低流量组支气管镜操作期间发生低氧血症的比值比为5.1(95%CI 3.2-8.2),p<0.001。

关键数值与推荐

  • 低流量氧疗起始速率4 L·min-1,逐渐增至12 L·min-1以维持SpO2>90%。
  • 高流量氧疗起始速率60 L·min-1,吸入氧浓度0.6,可增至80 L·min-1以维持SpO2>90%。

临床怎么用

  • 对接受支气管镜操作的COPD患者,可考虑使用经鼻高流量氧疗以减少操作中低氧血症。

局限性

  • 单中心、开放标签设计可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with COPD are at increased risk for developing additional respiratory comorbidities associated with smoking, and are thus prone to undergo flexible bronchoscopy. However, COPD patients have increased periprocedural complications risk and lower oxygen saturation during bronchoscopy. METHODS: This was an investigator-initiated, single-centre, open-label randomised controlled trial designed to assess the benefits of high-flow nasal oxygen compared to conventional low-flow oxygen by nasal cannula during conscious sedation for bronchoscopy in patients with COPD. Low flow was supplied at a starting rate of 4 L·min-1 and gradually increased up to 12 L·min-1 to maintain peripheral oxygen saturation (S pO2 ) >90%. High flow delivered starting at a rate of 60 L·min-1 and an inspiratory oxygen fraction of 0.6 was increased up to 80 L·min-1 to preserve S pO2 >90%. The primary end-point was cumulative hypoxaemia time. RESULTS: We randomised 600 COPD cases with a median (interquartile range (IQR)) age of 69.0 (62.0-76.0) years to either high flow (n=295) or low flow (n=305). The cumulative hypoxaemia time was 53% lower in the high-flow group (1.8% (95% CI 1.5-2.2%) versus 3.8% (95% CI 3.2-4.5%) of monitoring time; p<0.001). Additionally, the high-flow group experienced a median (IQR) of 3.0 (1.0-6.0) hypoxaemia events (S pO2 <90%) compared to 6.0 (3.0-10.0) in the low-flow group (p<0.001). The low-flow group had five-fold higher odds of experiencing hypoxaemia during bronchoscopy, (OR 5.1, 95% CI 3.2-8.2; p<0.001). CONCLUSION: High flow is feasible, decreases cumulative hypoxaemia time and reduces hypoxaemia events during bronchoscopy in patients with COPD but does not impact patient comfort.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Darie AM, Grize L, Jahn K, et al. Preventing oxygen desaturation during bronchoscopy in COPD patients using high-flow oxygen versus standard management: the randomised controlled PROSA 2 trial. Eur Respir J. 2025. PMID: 39947667. doi:10.1183/13993003.01586-2024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。